Rytary ER 23.75 MG-95 MG cap 100S
Ended Awarded
- Contract number
- SPE2DB26FABQ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,648
Award facts
- Contract value 100% obligated
- $2,647.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,647.88 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Rytary ER (levodopa/carbidopa extended-release) 23.75 mg-95 mg capsules in a quantity of 100 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction under AmerisourceBergen's existing federal contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to military healthcare systems worldwide. Rytary ER is a neurological treatment used primarily for Parkinson's disease management, consistent with AmerisourceBergen's extensive portfolio of specialty pharmaceuticals supporting Defense Health Agency and other federal healthcare systems. The company maintains a significant presence in federal medical procurement through open competition, delivering diverse pharmaceutical products ranging from small-value orders to substantial contracts exceeding $45,000.
Quick answers
Who was awarded contract SPE2DB26FABQ8?
SPE2DB26FABQ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FABQ8 worth?
The government has obligated $2,648 on SPE2DB26FABQ8.
Is contract SPE2DB26FABQ8 an order under another contract?
Yes. SPE2DB26FABQ8 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABQ8 competed?
The extent of competition for SPE2DB26FABQ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award